Be a PRO & get up to 50% off on select brands. Explore Now

Simply Save | Should you invest in healthcare funds launched by mutual funds?

In this Simply Save podcast, Moneycontrol’s Jash Kriplani speaks with Amol Joshi, founder of Plan Rupee Investment Services, to find out more.

May 25, 2021 / 06:01 PM IST

There have been several new fund launches in the mutual fund industry in the recent months. Fund houses have launched sectoral funds, as well as theme-based funds. 

Fund houses have been launching funds focusing on healthcare sector, as Covid-19 pandemic has highlighted importance of a strong healthcare sector. 

More recently, couple of fund houses launched healthcare funds in the shape of exchange traded funds. These will be passively-managed schemes that will just mimic an index. So, there will not be any role for active fund management. 

Should you invest in such funds or not, and if you must, how much of your investments should be put into such funds? 

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
In this Simply Save podcast, Moneycontrol’s Jash Kriplani speaks with Amol Joshi, founder of Plan Rupee Investment Services, to find out more.  
Moneycontrol News

stay updated

Get Daily News on your Browser
Sections